Senescence marker protein 30 is up-regulated in kainate-induced hippocampal damage through ERK-mediated astrocytosis

Journal of Neuroscience Research

Volumn 87, Issue 13, 2009, Pages 2890-2897

  Tae, Gen Son ^a   Hee, Ra Park ^a   So, Jung Kim ^a   Kim, Keunho ^a   Kim, Min Sun ^a   Ishigami, Akihito ^b,c   Handa, Setsuko ^c   Maruyama, Naoki ^c   Hae, Young Chung ^a   Lee, Jaewon ^a  

^a Pusan National University   (South Korea)

^b TOHO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Aging; Astrocytosis; Kainate; Microglia; Neurodegenerative diseases

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REGUCALCIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN INJURY; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; MALE; MICROGLIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEIZURE; UPREGULATION;

AGING; ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE; CEREBELLUM; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; GLIOSIS; HIPPOCAMPUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAINIC ACID; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RATS; RATS, INBRED F344; SEIZURES; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 70449449875     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22122     Document Type: Article

References (31)

1. Barja G. 2004. Free radicals and aging. Trends Neurosci 27:595-600.
2. Che Y, Yu YM, Han PL, Lee JK. 2001. Delayed induction of p38 MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure. Brain Res Mol Brain Res 94:157-165. (Pubitemid 32964757)
3. Crespo-Biel N, Canudas AM, Camins A, Pallas M. 2007. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus. Neurochem Int 50:435-442. (Pubitemid 46097174)
4. Feng D, Kondo Y, Ishigami A, Kuramoto M, Machida T, Maruyama N. 2004. Senescence marker protein-30 as a novel antiaging molecule. Ann N Y Acad Sci 1019:360-364. (Pubitemid 38951335)
5. Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J. 2001. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 137:1-11. (Pubitemid 32186610)
6. Ferrer I, Blanco R, Carmona M, Puig B, Dominguez I, Vinals F. 2002. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat. Acta Neuropathol 103:391-407. (Pubitemid 36097035)
7. Fiore RS, Murphy TH, Sanghera JS, Pelech SL, Baraban JM. 1993. Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J Neurochem 61:1626-1633. (Pubitemid 23317182)
8. Fujita T. 1999. Senescence marker protein-30 (SMP30): structure and biological function. Biochem Biophys Res Commun 254:1-4. (Pubitemid 29292005)
9. Fujita T, Shirasawa T, Uchida K, Maruyama N. 1992a. Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution. Biochim Biophys Acta 1132:297-305.
10. Fujita T, Uchida K, Maruyama N. 1992b. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1116:122-128.
11. Fujita T, Shirasawa T, Uchida K, Maruyama N. 1996. Gene regulation of senescence marker protein-30 (SMP30): coordinated up-regulation with tissue maturation and gradual down-regulation with aging. Mech Ageing Dev 87:219-229. (Pubitemid 26179139)
12. 2+-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 250:374-380.
13. Fujita T, Shirasawa T, Maruyama N. 1999. Expression and structure of senescence marker protein-30 (SMP30) and its biological significance. Mech Ageing Dev 107:271-280. (Pubitemid 29210229)
14. Furuichi Y, Noto T, Li JY, Oku T, Ishiye M, Moriguchi A, Aramori I, Matsuoka N, Mutoh S, Yanagihara T. 2004. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Res 1014:120-130. (Pubitemid 38798459)
15. Jung KJ, Ishigami A, Maruyama N, Takahashi R, Goto S, Yu BP, Chung HY. 2004. Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol 39:1169-1177. (Pubitemid 39024366)
16. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81:302-313.
17. Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K, Goto S, Nishikimi M, Maruyama N, Ishigami A. 2006. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA 103:5723-5728.
18. Kondo Y, Sasaki T, Sato Y, Amano A, Aizawa S, Iwama M, Handa S, Shimada N, Fukuda M, Akita M, Lee J, Jeong KS, Maruyama N, Ishigami A. 2008. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem Biophys Res Commun 377:291-296.
19. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA. 2004. Gene regulation and DNA damage in the ageing human brain. Nature 429:883-891. (Pubitemid 38843301)
20. Mariani E, Polidori MC, Cherubini A, Mecocci P. 2005. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Anal Technol Biomed Life Sci 827:65-75. (Pubitemid 41551598)
21. Ogita K, Takagi R, Oyama N, Okuda H, Ito F, Okui M, Shimizu N, Yoneda Y. 2001. Decrease in level of APG-2, a member of the heat shock protein 110 family, in murine brain following systemic administration of kainic acid. Neuropharmacology 41:285-293. (Pubitemid 32772922)
22. Otani N, Nawashiro H, Yano A, Katoh H, Ohnuki A, Miyazawa T, Shima K. 2003. Characteristic phosphorylation of the extracellular signal-regulated kinase pathway after kainate-induced seizures in the rat hippocampus. Acta Neurochir Suppl 86:571-573.
23. Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J. 2005. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79:522-534. (Pubitemid 40283352)
24. Radany EH, Brenner M, Besnard F, Bigornia V, Bishop JM, Deschepper CF. 1992. Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes. Proc Natl Acad Sci USA 89: 6467-6471.
25. Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M, Bendayan R. 2004. Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J Neurochem 89:788-800. (Pubitemid 38534163)
26. Serrano F, Klann E. 2004. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 3:431-443. (Pubitemid 39487899)
27. Son TG, Lee J. 2006. Importance of senescence marker protein 30 in aging and degenerative diseases. Kor J Gerontol 16:1-5.
28. Son TG, Zou Y, Jung KJ, Yu BP, Ishigami A, Maruyama N, Lee J. 2006. SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev 127:451-457.
29. Son TG, Kim SJ, Kim K, Kim MS, Chung HY, Lee J. 2008. Cytoprotective roles of senescence marker protein 30 against intracellular calcium elevation and oxidative stress. Arch Pharm Res 31:872-877.
30. Wang Q, Yu S, Simonyi A, Sun GY, Sun AY. 2005. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 31:3-16. (Pubitemid 41271190)
31. Wu G, Lu ZH, Wang J, Wang Y, Xie X, Meyenhofer MF, Ledeen RW. 2005. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. J Neurosci 25:11014-11022. (Pubitemid 41692631)